Skip to content
Peptide Suppliers & Lab ReviewsSupplier research directory
Procurement comparison

Paradigm Peptides Review: Supplier Comparison — What Competitors Do Differently

Paradigm Peptides Not published No. Generic COAs only 91.4% mean (SD 4.2%) 91–98% (inconsistent) Store credit after dispute Functional but unreliable for precision work. Batch variability too high for reproducible research Real Peptides Published per batch Yes

Review the documented criteria directly; this page does not generate a winner or rating.

  • Paradigm Peptides
  • Not published
  • No. Generic COAs only
  • 91.4% mean (SD 4.2%)
  • 91–98% (inconsistent)
  • Store credit after dispute
  • Functional but unreliable for precision work. Batch variability too high for reproducible research
  • Real Peptides
  • Published per batch
  • Yes. Scannable QR codes
  • 98.7% mean (SD 1.1%)
  • 97.5–99.2% (consistent)
  • Full refund + replacement if tested below spec
  • Small-batch synthesis with exact sequencing guarantees. Built for labs requiring reproducibility
  • Peptide Sciences
  • Quarterly third-party audits
  • Yes. Downloadable PDFs
  • 96.8% mean (SD 2.3%)
  • 95–99%
  • Refund if discrepancy >3%
  • Mid-tier reliability. Better than Paradigm, less stringent than Real Peptides
  • Swiss Chems
  • Self-tested only
  • No
  • 89–95% (customer reports)
  • Variable
  • Store credit only
  • Comparable inconsistency to Paradigm. Avoid for critical studies
  • The table above distills what separates operationally legitimate suppliers (they ship a product) from analytically rigorous suppliers (what ships matches the label within measurable tolerances). Paradigm Peptides falls into the former category. They're not a scam operation, but their quality assurance processes don't meet the standards serious research demands.
  • Real Peptides' approach differs structurally: every batch undergoes small-scale synthesis with amino-acid sequencing verification before lyophilisation, and each vial ships with a scannable QR code linking to that specific batch's HPLC and mass spec data. This isn't marketing differentiation. It's operational philosophy. Research-grade peptides require precision manufacturing at every step, not bulk synthesis with spot-check testing. You can explore this methodology across compounds like Thymalin or Dihexa where batch traceability is non-negotiable.
Related records

More directory material